-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$6.000.17% Upside
Abeona Therapeutics Inc. Frequently Asked Questions
-
What analysts cover Abeona Therapeutics Inc.?
Abeona Therapeutics Inc. has been rated by research analysts at Leerink Partners in the past 90 days.